Necrotizing Enterocolitis of the Newborn: Pathogenetic Concepts in Perspective

Uauy R , Fanaroff AA , Korones S , Necrotizing enterocolitis in very low birthweight infants: Biodemographic and clinical correlates. J Pediatr 1991;119:630–638.

Hack M , Horbar J , Malloy M , Very low birthweight outcomes of the National Institute of Child Health and Human Development neonatal network. Pediatrics 1991; 87:587–597.

Morecroft JA , Hamilton PA , Holmes SJK . Necrotizing enterocolitis—multisystem organ failure of the newborn? Acta Paediatr (Suppl) 1994;396:21–23.

Kliegman RM , Fanaroff AA . Medical progress: Necrotizing enterocolitis. N Engl J Med 1984;310:1093–1103.

Brown EG , Sweet AY . Neonatal necrotizing enterocolitis. Pediatr Clin North Am 1982;29:1149–1170.

Gupta SK , Burke G , Herson VC . Necrotizing enterocolitis: Laboratory indicators of surgical disease. J Pediatr Surg 1994;29:1472–1475.

Stoll J , Kanto WP Jr. , Glass R , Epidemiology of necrotizing enterocolitis: A case control study. J Pediatr 1980;96:447–451.

De Curtis M , Paone C , Vetrano G , A case control study of necrotizing enterocolitis occurring over 8 years in a neonatal intensive care unit. Eur J Pediatr 1987;146:398–400.

Rowe MI , Reblock KK , Kurkchubasche AG , Necrotizing enterocolitis in the extremely low birth weight infant. J Pediatr Surg 1994;29:987–991.

Hollwarth ME . Necrotizing enterocolitis: An editorial. Acta Paediatr (Suppl) 1994;396:1.

Bell MJ , Ternberg JL , Feigin RD , Neonatal necrotizing enterocolitis. Ann Surg 1978;187:1–7.

Walsh MC , Kliegman RM . Necrotizing enterocolitis: Treatment based on staging criteria. Pediatr Clin North Am 1986;33:179–201.

Benirschke K. Pathology of neonatal enterocolitis. In: Moore TD , ed. Necrotizing Enterocolitis in the Newborn Infant: Report of the 68th Ross Conference on Pediatric Research. Columbus, Ohio: Ross Laboratories, 1974;29–30.

DeSa DJ . The spectrum of ischemic bowel disease in the newborn. Perspect Pediatr Pathol 1976;3:273–309.

Polin RA , Pollack PF , Barlow B , Necrotizing enterocolitis in full-term infants: A case-control study. J Pediatr 1976;89:460–462.

Ballance WA , Dahms BB , Shenker N , Pathology of neonatal necrotizing enterocolitis: A ten-year experience. J Pediatr 1990;117:S6–S13.

Nowicki P. Intestinal ischemia and necrotizing enterocolitis. J Pediatr 1990;117:S14–S19.

Lloyd JR . The etiology of gastrointestinal perforations in the newborn. J Pediatr Surg 1969;4:77–84.

Kliegman RM , Hack M , Jones P , Fanaroff AA . Epidemiologic study of necrotizing enterocolitis among low-birth-weight infants. J Pediatr 1982;100:440–444.

Ross G. Escape of mesenteric vessels from adrenergic and nonadrenergic vasoconstriction. Am J Physiol 1971;221:1217–1222.

Bailey RW , Hamilton SR , Morris JB , Pathogenesis of nonocclusive ischemic colitis. Ann Surg 1986;203:590–599.

Crissinger KD , Kvietys PR , Granger DN . Developmental intestinal vascular responses to venous pressure elevation. Am J Physiol 1981;130:537–542.

Kosloske AM . A unifying hypothesis for pathogenesis of necrotizing enterocolitis. J Pediatr 1990;117:S68–S74.

Carbonaro CA , Clark DA , Elseviers D. A bacterial pathogenicity determinant associated with necrotizing enterocolitis. Microb Pathog 1988;5:427–436.

Gupta S , Morris JG , Panigrahi P , Endemic enterocolitis: Lack of association with a specific infectious agent. Pediatr Infect Dis J 1994;13:728–734.

Kliegman RM , Fanaroff AA , Izant R. Clostridia as pathogens in necrotizing enterocolitis. J Pediatr 1979;95:287–289.

Mollitt DL , Tepas JJ , Talbert JL . The role of coagulase negative staphylococcus in neonatal necrotizing enterocolitis. J Pediatr Surg 1988;23:60–63.

Rotbart HA , Nelson WL , Glode MP , Neonatal rotavirus-associated necrotizing enterocolitis: Case control study and prospective surveillance during an outbreak. J Pediatr 1988;112:87–93.

Joshi VV , Winston YE , Kay S. Neonatal necrotizing enterocolitis: Histologic evidence of healing. Am J Dis Child 1973;126:113–116.

Hsueh W , Gonzalez-Crussi F , Arroyave JL . Platelet-activating factor: An endogenous mediator for bowel necrosis in endotoxemia. FASEB J 1987;1:403–405.

Gonzalez-Crussi F , Hsueh W. Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. Am J Pathol 1983;112:127–135.

Hsueh W , Gonzalez-Crussi F , Arroyave JL . Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis. Am J Pathol 1986;122:231–239.

Sun XM , Hsueh W. Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest 1988;81:1328–1331.

Brown EG , Ainbender E , Henley WL , Hodes HL . Etiologic role of bacteria and intestinal function. In: Brown EG , Sweet AY , eds. Neonatal Necrotizing Enterocolitis. New York: Grune & Stratton, 1980;69–100.

Feuerstein G , Hallenbeck JM . Prostaglandins, leukotrienes, and platelet-activating factor in shock. Annu Rev Pharmacol Toxicol 1987;27:301–313.

Bone RC . The pathogenesis of sepsis. Ann Intern Med 1991;115:457–469.

Benveniste J. Paf-acether, an ether phospho-lipid with biological activity. Prog Clin Biol Res 1988;282:73–85.

Hanahan DJ . Platelet activating factor: A biologically active phosphoglyceride. Annu Rev Biochem 1986;55:483–509.

Handley DA . Platelet-activating factor as a mediator of endotoxin-related diseases. In: Handley DA , Saunders RN , Houlihan WJ , Tomesch JC , eds. Platelet-Activating Factor in Endotoxin and Immune Diseases. New York and Basel: Marcel Dekker, 1990;451–495.

Toth PD . The biological effects of PAF antagonists on endotoxemia. In: Handley DA , Saunders RN , Houlihan WJ , Tomesch JC , eds. Platelet-Activating Factor in Endotoxin and Immune Diseases. New York and Basel: Marcel Dekker, 1990;589–608.

Beutler B , Cerami A. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem 1988;57:505–518.

Zanetti G , Heumann D , Gerain J , Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopoly-saccharide. J Immunol 1992;148:1890–1897.

Tracey KJ , Beutler B , Lowry SF , Shock and tissue injury induced byrecombinant human cachectin. Science 1986;234:470–474.

Tracey KJ , Fong Y , Hesse DG , Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987;330:662–664.

Snyder F. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol 1990;259:C697–C708.

Denizot Y , Dassa E , Benveniste J , Paf-acether production by Escherichia coli. Biochem Biophys Res Commun 1989;161:939–943.

Sanchez-Crespo M , Alonso F , Inarrea P , Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: Evidence for a platelet independent mechanism. Immunopharmacology 1982;4:173–185.

Hsueh W , Gonzalez Crussi F , Arroyave JL , Platelet activating factor-induced ischemic bowel necrosis: The effect of PAF antagonists. Eur J Pharmacol 1986;123:79–83.

Stafforini DM , Elstad MR , McIntyre TM , Human macrophages secret platelet-activating factor acetylhydrolase. J Biol Chem 1990;265:9682–9687.

Tarbet EB , Stafforini DM , Elstad MR , Liver cells secrete the plasma form of platelet-activating factor acetyl-hydrolase. J Biol Chem 1991;266:16667–16673.

Tjoelker LW , Wilder C , Eberhardt C , Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 1995;374:549–553.

Zhang C , Hsueh W , Caplan MS , Kelly A. Platelet activating factor-induced shock and intestinal necrosis in the rat: Role of endogenous platelet-activating factor and effect of saline infusion. Crit Care Med 1991;19:1067.

Schandene L , Vandenbussche P , Crusiaux A , Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha and interleukin-6 by monocytes and T cells. Immunology 1992;76:30–34.

Giroir BP , Johnson JH , Brown T , The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest 1992;90:693–698.

Jaattela M. Biologic activities and mechanisms of action of tumor necrosis factor-α/cachectin. Lab Invest 1991;64:724–742.

Vilcek J , Lee TH . Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 1991;266:7313–7316.

Strieter RB , Kunkel SL , Bone RC . Role of tumor necrosis factor-α in disease states and inflammation. Crit Care Med 1993;21:S447–S463.

Camussi G , Bussolino F , Salvidio G , Baglioni C. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med 1987;166:1390–1404.

Valone FH , Epstein LB . Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma. J Immunol 1988; 141:3945–3950.

Hsueh W , Sun X , Rioja LN , Gonzalez-Crussi F. The role of the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin. Immunology 1990;70:309–314.

Sun X , Hsueh W. Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice. J Immunol 1991;147:509–514.

Huang L , Tan X , Crawford SE , Hsueh W. Platelet-activating factor and endotoxin induce tumour necrosis factor gene expression in rat intestine and liver. Immunology 1994;83:65–69.

Collart MA , Baeuerle P , Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol Cell Biol 1990;10:1489–1506.

Baeuerle PA . The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim Biophys Acta 1991;1072:63–80.

Tan X , Sun X , Gonzalez-Crussi FX , Gonzalez-Crussi F , Hsueh W. PAF and TNf increase the precursor of NF-kappa B p50 mRNA in mouse intestine: Quantitative analysis by competitive PCR. Biochim Biophys Acta 1994; 1215:157–162.

Deitch EA , Ma L , Ma WJ , Inhibition of endotoxin-induced bacterial translocation in mice. J Clin Invest 1989;84:36–42.

Sun X , Caplan MS , Liu Y , Hsueh W. Endotoxin resistant mice are protected from PAF-induced shock, tissue injury and death. Roles of TNF, complement activation and endogenous PAF production. Dig Dis Sci 1995;40:495–502.

Sun X , MacKendrick W , Tien J , Endogenous bacterial toxin is required for the injurious effect of PAF. Gastroenterology 1995;109:83–88.

Siren AL , Feuerstein G. Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats. Am J Physiol 1989;257:H25–H32.

Zhang C , Hsueh W. PAF-induced bowel necrosis. Effects of vasodilators. Dig Dis Sci 1991;36:634–640.

Hsueh W , Gonzalez-Crussi F , Arroyave JL . Release of leukotriene C₄ by isolated, perfused rat small intestine in response to platelet-activating factor. J Clin Invest 1986;78:108–114.

Hsueh W , Gonzalez-Crussi F , Arroyave JL . Sequential release of leukotrienes and norepinephrine in rat bowel after platelet-activating factor. A mechanistic study of platelet-activating factor-induced bowel necrosis. Gastroenterology 1988;94:1412–1418.

Cueva JP , Hsueh W. Role of oxygen derived free radicals in platelet activating factor induced bowel necrosis. Gut 1988;29:1207–1212.

Perdue MH , Ramage JK , Burget D , Intestinal mucosal injury is associated with mast cell activation and leukotriene generation during Nippostrongylus-induced inflammation in the rat. Dig Dis Sci 1989;34:724–731.

Ninio E , Joly F , Hieblot C , Bioxynthesis of pafacether. IX. Role for a phosphorylation-dependent activation of acetyltransferase in antigen-stimulated mouse mast cells. J Immunol 1987;139:154–160.

Zimmerman GA , Whatley RE , McIntyre TM , Prescott SM . Production of platelet-activating factor, a biologically active lipid, by vascular endothelial cells. Am Rev Respir Dis 1987;136:204–207.

Feinmark SJ . The role of the endothelial cell in leukotriene biosynthesis. Am Rev Respir Dis 1992;146:S51–S55.

Sun X , Qu X , Huang W , The role of leukocyte beta 2-integrin in PAF-induced shock and intestinal injury. Am J Physiol 1996;270:G184–G190.

Kubes P , Suzuki M , Granger DN . Platelet-activating factor-induced microvascular dysfunction: Role of adherent leukocytes. Am J Physiol 1990;258:G158–G163.

Kubes P , Arfors KE , Granger DN . Platelet-activating factor-induced mucosal dysfunction: Role of oxidants and granulocytes. Am J Physiol 1991;260:G965–G971.

Sun X , Rozenfeld RA , Qu X , Huang W , Gonzalez-Crussi , Hsueh W. P-selectin-deficient mice are protected from PAF-induced shock, intestinal injury, and lethality. Am J Physiol 1997;273:G56–G61.

Keshav S , Lawson L , Chung LP , Tumor necrosis factor mRNA localized to Paneth cells of normal murine intestinal epithelium by in situ hybridization. J Exp Med 1990;171:327–332.

Tan XD , Hsueh W , Gonzalez-Crussi F. Cellular localization of TNF-alpha transcripts in normal bowel and in necrotizing enterocolitis. TNF gene expression in Paneth cells, intestinal eosinophils and macrophages. Am J Pathol 1993;142:1858–1865.

Nevalainen TJ , Gronroos MJ , Kallajoki M. Expression of group II phospholipase A₂ in the human gastrointestinal tract. Lab Invest 1995;72:201–208.

Tan XD , Wang H , Gonzalez-Crussi FX , Chang H , Gonzalez-Crussi , Hsueh W. Platelet-activating factor and endotoxin increase the enzyme activity and gene expression of type II phospholipase A2 in the rat intestine. J Immunol 1996;156:2985–2990.

Wiswell T , Robertson C , Jones T , Necrotizing enterocolitis in full-term infants: A case-control study. Am J Dis Child 1988;142:532–535.

Leung M , Chau K , Hui P , Necrotizing enterocolitis in neonates with symptomatic congential heart disease. J Pediatr 1988;113:1044–1046.

Hackett GA , Campbell S , Gamsu H , Doppler studies in the growth retarded fetus and prediction of neonatal necrotizing enterocolitis, haemorrhage, and neonatal morbidity. Br Med J 1987;294:13–16.

Czyrko C , Del Pin CA , O'Neill JA , Maternal cocaine abuse and necrotizing enterocolitis: outcome and survival. J Pediatr Surg 1991;26:414–421.

Hansbrough F , Priebe CJ , Falterman KW , Pathogenesis of early necrotizing enterocolitis in the hypoxic neonatal dog. Am J Surg 1983;145:169–175.

Caplan MS , Sun X-M , Hsueh W. Hypoxia causes ischemic bowel necrosis in rats: The role of platelet-activating factor (PAF-acether). Gastroenterology 1990;99:979–986.

MacKendrick W , Caplan M. Necrotizing enterocolitis: New thoughts about pathogenesis and potential treatments. Pediatr Clin North Am 1993;40:1047–1059.

Musemeche CA , Kosloske AM , Bartow SA , Comparative effects of ischemia, bacteria and substrate on the pathogenesis of intestinal necrosis. J Pediatr Surg 1986;21:536–537.

Caplan M , Kelly A , Hsueh W. Endotoxin and hypoxia-induced intestinal necrosis in rats: The role of platelet activating factor. Pediatr Res 1992;31:428–434.

Moncada S , Higgs EA . The L-arginine–nitric oxide pathway. New Engl J Med 1993;329:2002–2012.

Caplan M , Hedlund E , Hill N , MacKendrick W. The role of endogenous nitric oxide and platelet-activating factor in hypoxia-induced intestinal injury in rats. Gastroenterology 1994;106:346–352.

MacKendrick W , Caplan M , Hsueh W. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat. Pediatr Res 1993;34:222–228.

Topalian SL , Ziegler MM . Necrotizing enterocolitis: A review of animal models. J Surg Res 1984;37:320–366.

Crissinger KD . Animal models of necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 1995;20:17–22.

Barlow B , Santulli TV , Heird WC , An experimental study of acute neonatal enterocolitis—the importance of breast milk. J Pediatr Surg 1974;9:587–594.

Pitt J , Barlow B , Heird WC . Protection against experimental necrotizing enterocolitis by maternal milk. I. Role of milk leukocytes. Pediatr Res 1977;11:906–909.

Barlow B , Santulli TV . Importance of multiple episodes of hypoxia or cold stress on the development of enterocolitis in an animal model. Surgery 1975;77:687–690.

Caplan MS , Hedlund E , Adler L , Hsueh W. Role of asphyxia and feeding in a neonatal rat model of necrotizing enterocolitis. Pediatr Pathol 1994;14:1017–1028.

Caplan MS , Hedlund E , Adler L , Lickerman M , Hsueh W. The platelet-activating factor receptor antagonists WEB 2170 prevents neonatal necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 1997;24:296–301.

Hu W , McNicholl IK , Choy PC , Man RYK . Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart. Br J Pharmacol 1993;110:645–650.

Mukherjee AB , Miele L , Pattabiraman N. Phospholipase A₂ enzymes: Regulation and physiological role. Biochem Pharmacol 1994;48:1–10.

Vadas P , Pruzanski W. Induction of group II phospholipase A₂ expression and pathogenesis of the sepsis syndrome. Circ Shock 1993;39:160–167.

Caplan MS , Sun X-M , Hsueh W , Hageman JR . Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 1990;116: 960–964.

MacKendrick W , Hill N , Hsueh W , Caplan M. Increase in plasma platelet-activating factor levels in enterally fed preterm infants. Biol Neonate 1993;64:89–95.

Amer MD , Caplan MS . Neonatal necrotizing enterocolitis increases platelet activating factor levels in the stool of newborn infants. Clin Res 1994;42:372A.

Farr RS , Wardlow ML , Cox CP , Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor. Federation Proc 1983;42:3120–3122.

Caplan M , Hsueh W , Kelly A , Donovan M. Serum PAF acetylhydrolase increases during neonatal maturation. Prostaglandins 1990;39:705–714.

Lucas A , Cole TJ . Breast milk and neonatal necrotizing enterocolitis. Lancet 1990;336:1519–1523.

Furukawa M , Lee EL , Johnston JM . Platelet-activating factor-induced ischemic bowel necrosis: The effect of platelet-activating factor acetylhydrolase. Pediatr Res 1993;34:237–241.